Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device

Abstract Background Hemolysis after Patent ductus arteriosus (PDA) device closure is rare. Although in most cases, hemolysis settles on its own; however, in some cases it may not settle spontaneously and may require additional procedures like putting additional coils, gel foam or thrombin instillati...

Full description

Bibliographic Details
Main Authors: Aamir Rashid, Ajaz Lone, Hilal Rather, Imran Hafeez
Format: Article
Language:English
Published: SpringerOpen 2023-03-01
Series:The Egyptian Heart Journal
Subjects:
Online Access:https://doi.org/10.1186/s43044-023-00343-8
_version_ 1797864370148999168
author Aamir Rashid
Ajaz Lone
Hilal Rather
Imran Hafeez
author_facet Aamir Rashid
Ajaz Lone
Hilal Rather
Imran Hafeez
author_sort Aamir Rashid
collection DOAJ
description Abstract Background Hemolysis after Patent ductus arteriosus (PDA) device closure is rare. Although in most cases, hemolysis settles on its own; however, in some cases it may not settle spontaneously and may require additional procedures like putting additional coils, gel foam or thrombin instillation, balloon occlusion, or removing it surgically. We report a case of adult PDA device closure who persisted with hemolysis and was managed by transcatheter retrieval. Case presentation A 52-year-old gentleman presented to us with a diagnosis of large PDA with operable hemodynamics. Descending thoracic aortic Angio showed a large 11 mm PDA. Transcatheter device closure was done in the same sitting with a 16 × 14 Amplatzer Ductal Occluder I(ADO) device,;however, after device release, the aortic end of the device was not fully formed and there was residual flow. The next morning patient started with gross hematuria with persistent residual flow. We tried to manage with conservative means including hydration, and blood transfusion; however, residual flow persisted for 10 days and his hemoglobin dropped from 13 gm/dl preprocedural to 7 gm/dl, creatinine increased from 0.5 mg/dl to 1.9 mg/dl, bilirubin increased to 3.5 mg/dl & urine showed hemoglobinuria. As the patient continued to deteriorate it was planned to retrieve the device by transcatheter approach. 10 French amplatzer sheath was parked in the pulmonary artery near the ductus. We tried with a combination of multiple catheters and Gooseneck snare (10 mm) and finally, we successfully retrieved with a combination of Multipurpose (MP) catheter and 10 mm Gooseneck snare. After that, we closed the defect successfully with a double disk device (muscular Ventricular septal defect 14 mm Amplatzer). The patient’s hematuria settled and was discharged after 2 days with normal hemoglobin and creatinine. Conclusions Patent ductus arteriosus ADO 1 device should not be released if the aortic end of the disk is not fully formed Patient should be carefully monitored for hemolysis if evidence of residual shunt and given supportive treatment. If conservative treatment fails, residual flow needs to be eliminated. Transcatheter retrieval although technically challenging is a feasible treatment. A muscular VSD device is a good alternative to the usual PDA device to close PDA, especially in adults.
first_indexed 2024-04-09T22:50:41Z
format Article
id doaj.art-a93dcc9b98d44f93ae8acd17513eb952
institution Directory Open Access Journal
issn 2090-911X
language English
last_indexed 2024-04-09T22:50:41Z
publishDate 2023-03-01
publisher SpringerOpen
record_format Article
series The Egyptian Heart Journal
spelling doaj.art-a93dcc9b98d44f93ae8acd17513eb9522023-03-22T11:39:14ZengSpringerOpenThe Egyptian Heart Journal2090-911X2023-03-017511410.1186/s43044-023-00343-8Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new deviceAamir Rashid0Ajaz Lone1Hilal Rather2Imran Hafeez3Department of Cardiology, SKIMSDepartment of Cardiology, SKIMSDepartment of Cardiology, SKIMSDepartment of Cardiology, SKIMSAbstract Background Hemolysis after Patent ductus arteriosus (PDA) device closure is rare. Although in most cases, hemolysis settles on its own; however, in some cases it may not settle spontaneously and may require additional procedures like putting additional coils, gel foam or thrombin instillation, balloon occlusion, or removing it surgically. We report a case of adult PDA device closure who persisted with hemolysis and was managed by transcatheter retrieval. Case presentation A 52-year-old gentleman presented to us with a diagnosis of large PDA with operable hemodynamics. Descending thoracic aortic Angio showed a large 11 mm PDA. Transcatheter device closure was done in the same sitting with a 16 × 14 Amplatzer Ductal Occluder I(ADO) device,;however, after device release, the aortic end of the device was not fully formed and there was residual flow. The next morning patient started with gross hematuria with persistent residual flow. We tried to manage with conservative means including hydration, and blood transfusion; however, residual flow persisted for 10 days and his hemoglobin dropped from 13 gm/dl preprocedural to 7 gm/dl, creatinine increased from 0.5 mg/dl to 1.9 mg/dl, bilirubin increased to 3.5 mg/dl & urine showed hemoglobinuria. As the patient continued to deteriorate it was planned to retrieve the device by transcatheter approach. 10 French amplatzer sheath was parked in the pulmonary artery near the ductus. We tried with a combination of multiple catheters and Gooseneck snare (10 mm) and finally, we successfully retrieved with a combination of Multipurpose (MP) catheter and 10 mm Gooseneck snare. After that, we closed the defect successfully with a double disk device (muscular Ventricular septal defect 14 mm Amplatzer). The patient’s hematuria settled and was discharged after 2 days with normal hemoglobin and creatinine. Conclusions Patent ductus arteriosus ADO 1 device should not be released if the aortic end of the disk is not fully formed Patient should be carefully monitored for hemolysis if evidence of residual shunt and given supportive treatment. If conservative treatment fails, residual flow needs to be eliminated. Transcatheter retrieval although technically challenging is a feasible treatment. A muscular VSD device is a good alternative to the usual PDA device to close PDA, especially in adults.https://doi.org/10.1186/s43044-023-00343-8HemolysisCatheter interventionAmplatzer duct occluder
spellingShingle Aamir Rashid
Ajaz Lone
Hilal Rather
Imran Hafeez
Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device
The Egyptian Heart Journal
Hemolysis
Catheter intervention
Amplatzer duct occluder
title Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device
title_full Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device
title_fullStr Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device
title_full_unstemmed Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device
title_short Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device
title_sort management of pda device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device
topic Hemolysis
Catheter intervention
Amplatzer duct occluder
url https://doi.org/10.1186/s43044-023-00343-8
work_keys_str_mv AT aamirrashid managementofpdadeviceclosurecomplicatedbyseverehemolysisbytranscatheterretrievalanddeploymentofnewdevice
AT ajazlone managementofpdadeviceclosurecomplicatedbyseverehemolysisbytranscatheterretrievalanddeploymentofnewdevice
AT hilalrather managementofpdadeviceclosurecomplicatedbyseverehemolysisbytranscatheterretrievalanddeploymentofnewdevice
AT imranhafeez managementofpdadeviceclosurecomplicatedbyseverehemolysisbytranscatheterretrievalanddeploymentofnewdevice